The results of genome-wide association studies have revealed that most human complex diseases (for example, cancer, diabetes and psychiatric disorders) are affected by a large number of variants, each of which explains a small increase in disease risk, suggesting a pattern of polygenic inheritance. At the same time, it has been argued that most complex diseases are genetically heterogeneous because many sporadic cases are observed, as well as cases with a family history. In this study, under the assumption of polygenic inheritance, we derive the expected proportion of sporadic cases using analytical methods and simulation. We show how the proportion of sporadic cases depends on disease prevalence (K) and heritability on the underlying liability scale (h L 2 ). We predict the underlying heritability and the proportion of sporadic cases for a range of human complex diseases, and show that this proportion is typically large. For a disease with h L 2 ¼63% and K¼0.4%, such as schizophrenia, 483% of proband cases are predicted to be sporadic (no affected first-, second-and third-degree relatives) in typical families (on an average, two children per couple). For the majority of these diseases, a large proportion of sporadic cases is expected under the polygenic model, implying that the observed large proportion of sporadic cases is not informative to the causal mechanism of a complex genetic disease. European Journal of Human Genetics (2010Genetics ( ) 18, 1039Genetics ( -1043 doi:10.1038/ejhg.2009 published online 14 October 2009 Keywords: sporadic case; polygenic inheritance; complex disease INTRODUCTION Large-scale, high-density genome-wide association studies (GWAS) have greatly facilitated the discovery of genetic variants that affect the predisposition to human complex diseases. 1 The results of recent GWAS suggest that the majority of susceptible loci have small contributions to phenotypic variation, which indicates that there should be a large number of susceptibility loci involved in the genetic basis of complex disease. [2] [3] [4] [5] [6] [7] [8] These findings are consistent with the polygenic model, proposed almost a century ago, 9 underlying the genetic etiology of complex diseases. At the same time, on the basis of the knowledge of family history, differentiation is often made between sporadic and familial cases. This differentiation implies some sort of genetic heterogeneity, either that environmental factors are more important in sporadic cases or that sporadic cases arise from new mutations of large effect size. Integrating this differentiation into an understanding of the genetic architecture of complex disease depends on the frequency of sporadic cases, consistent with the polygenic model.
INTRODUCTION
Large-scale, high-density genome-wide association studies (GWAS) have greatly facilitated the discovery of genetic variants that affect the predisposition to human complex diseases. 1 The results of recent GWAS suggest that the majority of susceptible loci have small contributions to phenotypic variation, which indicates that there should be a large number of susceptibility loci involved in the genetic basis of complex disease. [2] [3] [4] [5] [6] [7] [8] These findings are consistent with the polygenic model, proposed almost a century ago, 9 underlying the genetic etiology of complex diseases. At the same time, on the basis of the knowledge of family history, differentiation is often made between sporadic and familial cases. This differentiation implies some sort of genetic heterogeneity, either that environmental factors are more important in sporadic cases or that sporadic cases arise from new mutations of large effect size. Integrating this differentiation into an understanding of the genetic architecture of complex disease depends on the frequency of sporadic cases, consistent with the polygenic model.
In this study, we investigate the relative proportion of sporadic and familial cases expected under the polygenic threshold model. We assume that disease susceptibility is genetically homogeneous in the population and the observed illness results from the accumulative effect of multiple common genetic and environmental effects that exceeds a certain threshold. [10] [11] [12] [13] We conducted a simulation study to calculate the probability of a proband case without family history. Furthermore, we investigated the relationship of disease prevalence, heritability of liability, recurrence risk (RR) and family size, and analytically predicted heritability of liability and the proportion of sporadic cases in human complex diseases under the polygenic model.
METHODS AND RESULTS
We simulated pedigrees with three generations. For each pair of parents in the first and second generations, the number of offspring was independently drawn from a Poisson distribution, as in Cui and Hopper. 14 The structure of the simulated pedigree is illustrated in Figure 1 . The disease liability (y) of each individual in the pedigree was simulated by a simple genetic model y¼a+e, where a is the additive genetic effect; e is the environmental effect; e $ Nð0; 1 À h 2 L Þ; and h L 2 is the narrow sense heritability of liability. The additive effects of the individuals in the first generation were drawn from a $ Nð0; h 2 L Þ, whereas those in the second and third generations were generated by a¼0.5a F +0.5a M +m, where a F and a M are the additive effects of parents, and m is the effect due to Mendelian segregation, m $ Nð0; 0:5h 2 L Þ (Appendix). A range of heritability levels (h L 2 ¼0, 10,y100%), along with three levels of disease prevalence (K¼10, 1 and 0.1%), was considered to be representative of human complex diseases. An individual was considered to be diseased if y4T, where T is the threshold on the normal distribution truncating the proportion K. A total of 100 000 pedigrees with at least one disease case (proband) in the third generation were generated for each of combinations of h L 2 , K and S, where S is the mean family size per couple. A proband case was considered to have a family history of disease on the basis of two different definitions: (I) at least one first-degree relative with disease, and (II) at least one first-, second-or third-degree (11, 21 or 31, illustrated in Figure 1 ) relative is affected, and the probability of a sporadic case was defined accordingly.
It is shown in Figure 2 that P(sporadic) depends mainly on disease prevalence K. It increases markedly with decreasing K, and gradually increases with decreasing h L 2 and S. For a disease with a prevalence of 0.1%, a proband case has a probability of B78% (definition I) or B70% (definition II) to be sporadic, even if the heritability of disease is 100% and family size is large (S¼5). We investigated the relationship between the underlying and observed scale. In theory, P(sporadic) is approximately equal to Q n ½FðT n Þ fn , where Fð:Þ is standard normal cumulative distribution function; f n is the number of n th -degree
with i¼z/K; and z is the height of the standard normal curve at the truncation point T (Appendix). For example, when S¼2 and for diseases with prevalence ranging from 0.1 to 1%, P(sporadic) will range from 66 to 99% (definition I) or from 52 to 99% (definition II), with hL 2 from 100 to 0%. Therefore, for these diseases, the proband cases observed in typical families will more likely seem to be sporadic no matter how heritable the disease is. By contrast, a large proportion of probands would present with a family history for a disease with a high prevalence (K¼0.1); even if the heritability is extremely low (hL 2 ¼10%), there are 31% (definition I) or 65% (definition II) of probands having a family history. In addition, the nth-degree RR can be calculated analytically as l n ¼ ½1 À FðT n Þ=K (Appendix). The RRs for relatives from this equation were verified by simulations and are listed in Table 1 . In line with the results for P(sporadic), RRs largely depended on disease prevalence K. Although the relationship of hL 2 , K and ln is theoretically nonlinear, the relationship between log(l1) and ÀhL 2 log(K) is approximately linear for each K (Figure 3 ), and is roughly log(l1)¼À0.62 hL 2 log(K) with regression R 2 ¼99.4% for K from 0.01 to 10%. Figure 3 Empirical relationship of disease prevalence (K), heritability on underlying scale (h L 2 ) and first-degree recurrence risk (l 1 ). In the figure, y¼log(l 1 ) and x¼Àh L 2 log(K).
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An analytical method to calculate h L 2 using K and l 1 is provided in the Appendix. We used this method to predict heritability of liability for a range of common complex diseases using the observable parameters, namely, disease prevalence and first-degree RR (Table 2) . Given h L 2 and K of disease, we also predicted P(sporadic) from our analytical approximation and checked all our analytic results by simulation. The predictions of P(sporadic) for these diseases are presented in Table 2 . The predictions of P(sporadic) from simulation agreed well with those from approximation, with a correlation of 0.998.
DISCUSSION
Using the relationship between underlying and observed scale parameters under a polygenic inheritance model, we predicted h L 2 for a list of human complex diseases, using K and l 1 collected from literature. The proportion of sporadic cases and RRs for relatives depends mainly on disease prevalence. If we consider three-generation pedigrees with S¼2, then for diseases with a low prevalence (Ko1%), even if they are highly heritable (h L 2 ¼90%), the disease cases will seem more likely to be sporadic, P(sporadic II) 463% (Figure 2b ). On the other hand, for a disease with a high prevalence (K 410%), a large proportion of disease cases seems to have a family history, P(sporadic II) o37% (Figure 2b ), even when disease heritability is extremely low (h L 2 ¼10%). Kendler 15 modeled familial versus sporadic schizophrenia and major depression using simple genetic and environment etiology models. He showed that family history had a high positive predictive value, but a low negative predictive value. Under the liability threshold model, these results still apply, that is, a positive family history implies a high genetic liability to disease and a negative family history implies very little about genetic liability to disease.
Our results necessarily reflect our assumptions in modeling complex genetic disease. First, we assumed that the causes of familiality of complex disease reflect only genetic rather than family environment factors. As more distant relatives are less likely to share the same The disease prevalence (K) and first-degree recurrence risk (l 1 ) are obtained from the literature and may include averaging over sexes. h L 2 is calculated from its analytical relationship with K and l 1 (Appendix). a S is the mean family size per couple. b Theor. represents the predictions of P(sporadic) by analytical approximation. c Simu. represents the predictions of P(sporadic) by simulation.
Sporadic cases are the norm for complex disease J Yang et al environmental risk factors, this assumption can be tested by comparing RRs for different types of relatives with their expected values under a genetic etiology model. Second, we used idealized family history assuming that the true disease status of all relatives is known, ignoring recall errors and age of onset factors. This implies that our estimates of proportion of sporadic cases are conservative and in practice may be even higher than our prediction. Moreover, in some diseases, family history reflects increased severity of the disease, 16 which, although not inconsistent with a polygenic model, may imply genetic heterogeneity. Finally, we assumed that a liability threshold model is representative of complex genetic diseases. The model assumes a normally distributed liability to disease, with disease occurring in those who exceed a liability threshold. A normal distribution of liability would be achieved if there are multiple genetic and environmental factors, each making a small contribution to the risk of disease. Comparison of the prediction frequency of familial versus sporadic cases provides some benchmark for the validity of our assumptions. For example, a Swedish population study investigated breast cancer in 1 732 775 sisters from 763 963 families (S¼2.3) before the age of 70 years. 17 A total of 16 505 proband cases and 714 sisters of probands were identified with breast cancer, which provides the estimates of K¼1% and l s ¼3 for breast cancer before the age of 70 years. We predicted an h L 2 of 35% by our analytical equation. Given K and h L 2 , we simulated 1 million nuclear families with S¼2.3, and estimated a multiplex proportion of siblings (the number of families with at least two affected siblings divided by the number with at least one sibling) of 4.6%, with 95% CI of 4.2% B5.0%, which is consistent with the observed proportion of 4.3%.
We consider the example of schizophrenia. The prevalence of sporadic versus familial cases has been considered in detail under a range of genetic models 15, 18 in the context of etiological heterogeneity of schizophrenia. The latest evidence from GWAS for schizophrenia points to a large polygenic component. 19 At the same time, significantly increased rates of de novo copy number variant (CNV) mutations have been reported in sporadic (but not familial) cases of schizophrenia, 20 together implying genetic heterogeneity. In combination, these results point to many risk alleles that have a range of frequencies and effect sizes but that are still consistent with a normally distributed underlying liability to disease. Genetic epidemiology parameters of schizophrenia are classically quoted to be K¼1%, l 1 ¼8.6 and h L 2 ¼81%, 21 but results from a Swedish population sample of 49 million have revised these estimates to K¼0.4%, l 1 ¼9 and h L 2 ¼64%. 22, 23 For K¼0.4% and l 1 ¼9, we predict h L 2 to be 63%, and for K¼1% and l 1 ¼8.6, we predict h L 2 to be 80%, reflecting that under a threshold liability model, the lower disease prevalence forces a lower estimate of h L 2 for the same l 1 . For K¼0.4% and h L 2 ¼63%, we predict the proportion of sporadic schizophrenia cases to be 90% (definition I) and 83% (definition II) in three-generation pedigrees with S¼2 ( Table 2 ). The Swedish population study observed a multiplex proportion of 3.8% (the number of families with at least two affected members divided by the number with at least one affected member) 17 from nuclear families with B3.8 members per family. 16 We simulated 1 million nuclear families with S¼1.8, and estimated the multiplex proportion as 4.0% (95% CI of 3.7-4.4% from 100 simulation replicates) and P(sporadic I) as 90.6% (95% CI of 89.7-91.5%).
In conclusion, although sporadic cases can arise from nongenetic risk factors and from new mutations with large effects, a large proportion of sporadic cases is expected under the polygenic model, a result that reflects the relatively low prevalence rates (o5%) that are typical of common complex genetic diseases. Therefore, it is not possible to make any inference with regard to the causal mechanism of a complex disease from the observed proportion of sporadic cases alone. 
where h L 2 is the heritability of liability and z is the height of the standard normal curve at the truncation point T pertaining to a disease prevalence of K.
Given a proband case, the probability of the n th -degree relative being is
where Fð:Þ is standard normal cumulative distribution function and
Therefore, the nth-degree RR is l n ¼ 1 À FðT n Þ=K, which provides a link between the underlying liability scale and the observed risk scale.
In particular, the RR to MZ twin is l MZ ¼ l 0 ¼ ð1 À FðT 0 Þ=KÞ. Following James, 25 the n th -degree RR can also be expressed as l n ¼ 1+cov 01 ðX; R n Þ=K 2 , where cov 01 ðX; R n Þ is the covariance between the proband case and its nth-degree relatives on the observed 0-1 scale, hence cov 01 ðX; R n Þ ¼ ½1 À K À FðT n ÞK. Therefore, the heritability on the observed 0-1 scale is 
This approximation is a conservative prediction of P(sporadic) because the probabilities of affected relatives are not independent, especially when both K and h L 2 are high and lots of relatives are included.
All the derivations above begin with K and h L 2 being known parameters; in practice, however, only l n and K are observable. Given l 1 and K, h L 2 can be predicted by rearranging Eq. A1 for n ¼1 and solving for h L 2 . 24, 26 h 2 L ¼ 2½T À T 1 ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi 1 À ðT 2 À T 2 1 Þð1 À T=iÞ p i+T 2 1 ði À TÞ where T 1 is truncation point pertaining to the accumulative probability FðT 1 Þ ¼ 1 À l 1 K.
